PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Surgical Oncology, Department of Surgery, The Ohio State University Wexner Medical Center James Comprehensive Cancer Center, Columbus, OH, USA. Koun.park@ousmc.edu.\', \'The Ohio State University Wexner Medical Center, 410 W 10th Ave, N908 Doan Hall, Columbus, OH, 43210, USA. Koun.park@ousmc.edu.\', \'Department of Biomedical Informatics, The Ohio State University Wexner Medical Center, Columbus, OH, USA.\', \'Department of Radiation Oncology, The Ohio State University Wexner Medical Center James Comprehensive Cancer Center, Columbus, OH, USA.\', \'Division of Medical Oncology, Department of Medicine, The Ohio State University Wexner Medical Center James Comprehensive Cancer Center, Columbus, OH, USA.\', \'Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.\', \'Memorial Sloan Kettering Cancer Center, New York, NY, USA.\', \'Division of Medical Oncology, Department of Medicine, University of Kansas Medical Center, Westwood, KS, USA.\', \'Section of Medical Oncology, Department of Medicine, Yale University, New Haven, CT, USA.\', \'Division of Surgical Oncology, Department of Surgery, The Ohio State University Wexner Medical Center James Comprehensive Cancer Center, Columbus, OH, USA.\', \'Department of Surgery, Baylor College of Medicine, Houston, TX, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s10549-021-06153-3
?:doi
?:hasPublicationType
?:journal
  • Breast cancer research and treatment
is ?:pmid of
?:pmid
?:pmid
  • 33651271
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.066
?:rankingScore_hIndex
  • 133
?:title
  • Neoadjuvant endocrine therapy use in early stage breast cancer during the covid-19 pandemic.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all